These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 14555984)
1. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells. Zhang XQ; Kondrikov D; Yuan TC; Lin FF; Hansen J; Lin MF Oncogene; 2003 Oct; 22(43):6704-16. PubMed ID: 14555984 [TBL] [Abstract][Full Text] [Related]
2. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Zelivianski S; Verni M; Moore C; Kondrikov D; Taylor R; Lin MF Biochim Biophys Acta; 2001 May; 1539(1-2):28-43. PubMed ID: 11389966 [TBL] [Abstract][Full Text] [Related]
4. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells. Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372 [TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features. Alberti C G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206 [TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
7. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cox ME; Deeble PD; Lakhani S; Parsons SJ Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001 [TBL] [Abstract][Full Text] [Related]
8. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Yuan TC; Veeramani S; Lin MF Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716 [TBL] [Abstract][Full Text] [Related]
11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells. Berenguer C; Boudouresque F; Dussert C; Daniel L; Muracciole X; Grino M; Rossi D; Mabrouk K; Figarella-Branger D; Martin PM; Ouafik L Oncogene; 2008 Jan; 27(4):506-18. PubMed ID: 17637748 [TBL] [Abstract][Full Text] [Related]
13. Expression of receptor protein tyrosine phosphatase alpha mRNA in human prostate cancer cell lines. Zelivianski S; Dean J; Madhavan D; Lin FF; Lin MF Mol Cell Biochem; 2000 May; 208(1-2):11-8. PubMed ID: 10939623 [TBL] [Abstract][Full Text] [Related]
14. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells. Wright ME; Tsai MJ; Aebersold R Mol Endocrinol; 2003 Sep; 17(9):1726-37. PubMed ID: 12775765 [TBL] [Abstract][Full Text] [Related]
16. Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells. McKeithen D; Graham T; Chung LW; Odero-Marah V Prostate; 2010 Jun; 70(9):982-92. PubMed ID: 20166136 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. Miyake H; Nelson C; Rennie PS; Gleave ME Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316 [TBL] [Abstract][Full Text] [Related]
18. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines. Guo C; Luttrell LM; Price DT J Urol; 2000 Mar; 163(3):1027-32. PubMed ID: 10688043 [TBL] [Abstract][Full Text] [Related]
19. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells. Meng TC; Lee MS; Lin MF Oncogene; 2000 May; 19(22):2664-77. PubMed ID: 10851066 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Lee LF; Guan J; Qiu Y; Kung HJ Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]